Immediate Impact
8 from Science/Nature 59 standout
Citing Papers
Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer
2024 Standout
New promises and challenges in the treatment of advanced non-small-cell lung cancer
2024 Standout
Works of Andreas H. Scheel being referenced
Abstract HER2-13: HER2-13 Proficiency assessment of HER2-low breast cancer scoring with the Ventana PATHWAY 4B5 and Dako HercepTest HER2 assays and the impact of pathologist training
2023
PD-L1 expression in non-small cell lung cancer: Correlations with genetic alterations
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Andreas H. Scheel | 1018 | 526 | 457 | 54 | 1.6k | |
| Nisha Mohindra | 722 | 436 | 359 | 63 | 1.3k | |
| Élodie Vauléon | 583 | 406 | 507 | 60 | 1.7k | |
| Dana T. Aftab | 869 | 567 | 794 | 45 | 1.8k | |
| Maria Gabriela Raso | 998 | 801 | 908 | 56 | 2.0k | |
| Ian McCaffery | 867 | 538 | 590 | 43 | 1.8k | |
| Viive M. Howell | 653 | 413 | 841 | 73 | 2.2k | |
| Arne Scholz | 979 | 475 | 698 | 63 | 1.8k | |
| Chunyan Wu | 1007 | 958 | 581 | 67 | 1.8k | |
| Jimmy Ruiz | 964 | 1065 | 543 | 100 | 2.1k | |
| Chan-Young Ock | 1004 | 501 | 301 | 42 | 1.4k |
All Works
Login with ORCID to disown or claim papers
Loading papers...